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Abstract
Effective cell invasion into thick electrospun biomimetic scaffolds is an unsolved problem. One possible strategy to 
biofabricate tissue constructs of desirable thickness and material properties without the need for cell invasion is to 
use thin (<2 µm) porous electrospun meshes and self-assembling (capable of tissue fusion) tissue spheroids as building 
blocks. Pre-stretched electrospun meshes remained taut in cell culture and were able to support tissue spheroids with 
minimal deformation. We hypothesize that elastic electrospun scaffolds could be used as temporal support templates 
for rapid self-assembly of cell spheroids into higher order tissue structures, such as engineered vascular tissue. The aim 
of this study was to investigate how the attachment of tissue spheroids to pre-stretched polyurethane scaffolds may 
interfere with the tissue fusion process. Tissue spheroids attached, spread, and fused after being placed on pre-stretched 
polyurethane electrospun matrices and formed tissue constructs. Efforts to eliminate hole defects with fibrogenic tissue 
growth factor-β resulted in the increased synthesis of collagen and periostin and a dramatic reduction in hole size and 
number. In control experiments, tissue spheroids fuse on a non-adhesive hydrogel and form continuous tissue constructs 
without holes. Our data demonstrate that tissue spheroids attached to thin stretched elastic electrospun scaffolds 
have an interrupted tissue fusion process. The resulting tissue-engineered construct phenotype is a direct outcome 
of the delicate balance of the competing physical forces operating during the tissue fusion process at the interface of 
the pre-stretched elastic scaffold and the attached tissue spheroids. We have shown that with appropriate treatments, 
this process can be modulated, and thus, a thin pre-stretched elastic polyurethane electrospun scaffold could serve as 
a supporting template for rapid biofabrication of thick tissue-engineered constructs without the need for cell invasion.
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Introduction
Electrospinning is rapidly emerging as a platform technol-
ogy for the fabrication of new generations of nanostruc-
tured scaffolds.1–3 Studies indicate that electrospun 
nanoscaffolds may be useful in the biofabrication of vascu-
lar tissue engineering constructs.4–8 Further investigations 
in this direction have shown that electrospun scaffolds act 
as excellent biomimetic nanosubstrates for the adhesion 
and spread of vascular endothelial cells9 and smooth mus-
cle cells.5,10 Electrospun scaffolds are, however, difficult to 
cellularize because they offer only a limited degree of cell 
invasion. Several new technologies have emerged in an 
attempt to overcome this limitation, such as the simultane-
ous electrospinning of encapsulated cells and fibers,11,12 the 
combined use of “sacrificial” (rapidly degradable) and non-
sacrificial electrospun fibers,13 the development of bilay-
ered elastomeric scaffolds,14 and pore micromachining 
using femtosecond laser ablation.15 While each of these 
methods shows early promise, further investigation into the 
effective cellularization of electrospun scaffolds remains a 
justifiable endeavor. One possible strategy to circumvent 
this issue is to use thin electrospun scaffolds as templates 
for self-assembling fusogenic (capable of tissue fusion) tis-
sue spheroids. Thin elastic electrospun scaffolds are suita-
ble to provide structure and support to enable rapid fusion 
of individual cell spheroids into tissue constructs of desir-
able thickness, while retaining physical and handling prop-
erties that are practical for subsequent biofabrication into 
higher order tissue structures. Moreover, the high porosity 
and limited thickness of the nanofiber scaffold will allow 
for continuous direct cell–cell contact between each layer 
in contrast to bulk material templating approaches.16
Tissue spheroids are cell aggregates of sphere-like shape 
that provide the highest possible initial cell density for tissue 
engineering and are therefore useful as three-dimensional 
(3D) building blocks for solid scaffold-free tissue engineer-
ing.17–19 Experiments show that two closely placed tissue 
spheroids fuse into one new spheroid of larger diameter.20,21 
This process, named tissue fusion, is a ubiquitous process 
during embryonic development22 and can be referred to as a 
biomimetic approach to tissue engineering.23,24 The fusion 
of tissue spheroids is a fundamental biological principle and 
biophysical basis of the emerging bottom-up solid-scaffold-
free tissue engineering approach. Tissue spheroids have 
since been implemented in the fabrication of myocardial tis-
sue,25–28 nervous tissue,29,30 and other tissues. More recent 
studies show that tissue spheroids could be useful in vascu-
lar tissue engineering17 and that vascular tissue spheroids 
and rods could be used to form the branched segments of 
vascular tree.31,32 It has also been demonstrated that liver 
tissue spheroids can be attached and immobilized on elec-
trospun nanofiber matrices.33
Tissue fusion is driven by surface tension forces and is 
most effective within a hanging drop or fluid environment. 
The fusion of tissue spheroids can also occur in hydrogels 
or extracellular matrix substrates; however, the process is 
strongly dependent on the properties of these substrates.34 
The behavior of tissue spheroids and, more specifically, 
the tissue fusion processes of vascular tissue spheroids 
attached to an electrospun scaffold have not yet been sys-
tematically investigated. We hypothesize that electrospun 
scaffolds could be used as temporal support templates for 
vascular tissue spheroids in the assembly of vascular tis-
sue. Thus, the goal of this study was to evaluate electro-
spun scaffolds as support templates for rapid tissue 
fusion–mediated vascular tissue spheroid bioassembly 
into tissue constructs. The secondary objective is to dem-
onstrate the potential of this approach for subsequent bio-
fabrication of higher order tissue structures, especially in 
vascular applications. Mechanically biomimetic pre-
stretched elastic electrospun polyurethane (PU) nanofibers 
have been selected as supporting scaffold. Nanofiber ten-
sion present in the pre-stretched electrospun scaffolds 
allows for very thin nanofiber meshes to support multicel-
lular spheroids with minimal deformation. The elasticity 
of the electrospun PU scaffolds is essential for subsequent 
biofabrication of templated fused spheroids into higher 
order structures and for bioreactor-based biomechanical 
conditioning of vascular tissue-engineered constructs. 
Tissue spheroids were derived from human adipose tissue–
derived stem cells (ADSCs) as a clinically relevant cells 
source. ADSCs have been used because they represent an 
autologous cell source with proven capacity to be directly 
differentiated into smooth muscle cell lineage and can be 
isolated during very short time in large amounts from 
patient’s liposucted adipose tissue using commercially 
available clinical sorters. Potent fibrogenic factor tissue 
growth factor (TGF)-β1 has been used to enhance the 
material properties of tissue-engineered constructs by 
inducing extracellular matrix deposition.
The novel data presented in this article demonstrate that 
pre-stretched electrospun PU scaffolds can interfere with 
tissue fusion and the bioassembly of tissue spheroids into 
tissue-engineered constructs. The data also indicate that a 
combination of solid scaffold–based and tissue spheroid–
based tissue engineering approaches is feasible and offers 
new and exciting opportunities for self-directed tissue 
assembly. The dynamics of electrospun scaffold–tissue 
spheroid interactions are more complex than originally 
expected; however, scaffold–spheroid interactions could 
be optimized and balanced by using TGF-β1 treatment. 
Thus, further study into the visualization and measurement 
of the physical forces controlling the tissue spheroid fusion 
process on pre-stretched PU scaffolds is warranted.
Materials and methods
Cell culture
ADSCs (Invitrogen) were re-expanded in MesenPRO 
RS Basal Medium (Invitrogen) and supplemented with 
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MesenPRO RS Growth Supplement (Invitrogen), 1% 
Penicillin/Streptomycin (Invitrogen), 1% L-glutamine 
(Invitrogen, USA), and 1% AmphotericineB (Invitrogen). 
Cells were maintained in a humidified incubator at 37°C 
in 5% CO2–95% air atmosphere and new media every 
second day. Cells from the third passage were used for 
tissue spheroid biofabrication.
Tissue spheroid biofabrication
Tissue spheroids were fabricated in the conventional hanging 
drop method.35 Cells were harvested from confluent mon-
olayers by treatment with 0.25% Trypsin/ethylenediaminetet-
raacetic acid (EDTA) for 5 min in a humidified incubator. The 
cells were counted and the concentration of the cell suspen-
sion was adjusted to 106 cell/mL (25,000 cell/25 mL). Droplets 
of 25 mL were placed on the lids of Petri dishes that were 
inverted and incubated at 37°C. After 48 h of incubation, the 
cells were self-assembled into tissue spheroids at the bottom 
of the droplets by gravitational force.
Scaffold fabrication
PU (Tecoflex SG-80A; Noveon, Cleveland, OH, USA) 
was dissolved in hexafluoro-2-propanol (HFIP; Oakwood, 
West Columbia, SC) at a concentration of 8% (wt/v). The 
solution was electrospun through a blunt tipped 21G nee-
dle at a voltage of 10 kV, flow rate of 0.015 mL/min, and 
drop height of 11 cm. Fibers were collected in aligned 
arrays of 7-cm-long nanofibers across a polycarbonate 
rack using a custom-built collection device.36 The device 
utilizes two parallel mobile tracks to collect aligned fiber 
arrays and pull them down to a secondary collecting area 
at a vertical speed of 10 mm/s. Four single-layer aligned 
nanofiber sheets collected at 7.5-min intervals were fixed 
to a square polycarbonate rack oriented in a 90° criss-
crossed pattern. Scaffolds were sterilized in 1N HCl for 
30 min.
Scanning electron microscopy
Samples were sputter coated with gold at a thickness of 
50–70 nm using a Cressington 108 AUTO sputter-coater 
with a current of 30 mA for 2 min. Images of the samples 
were taken at 500–10,000 times magnification using a 
scanning electron microscope (SEM; Hitachi TM-1000, 
Japan).
Tissue spheroid fusion experiments
Tissue spheroids biofabricated using hanging drop method 
were manually placed on electrospun PU scaffold; 1, 2, 3, 
7, and 50 spheroids were placed as separated clusters. The 
plastic frame comprising the electrospun scaffold and the 
attached tissue spheroids were placed in Petri dish with 
cell culture media. The kinetics of tissue spheroid 
attachment, spreading, and fusion were monitored daily 
using an inverted light microscope. Tissue spheroids have 
been photographed every day after their seeding on elec-
trospun matrices during 1 week.
Biofabrication of tissue-engineered construct
Tissue-engineered constructs suitable for biomechanical 
testing were biofabricated from self-assembling tissue 
spheroids cultured on electrospun scaffolds that were spe-
cially designed to be very thin and compliant. The average 
thickness of tissue constructs was 20 ± 3 µm. The average 
thickness of the PU electrospun scaffold was 1.68 ± 0.82 µm, 
and interfibrillar space was 10.6 ± 4.3 µm. Approximately 
1000 tissue spheroids were placed on each scaffold in 
standard place. Supporting frames with attached tissue 
spheroids were placed in Petri dishes. Tissue spheroid 
fusion kinetics were analyzed using an inverted light micro-
scope. Specific areas of standard size were randomly 
selected and photographed under standard magnification 
for morphometric analysis. The constructs were incubated 
in TGF-β1 up to 2 weeks in order to investigate the feasibil-
ity of accelerated tissue maturation. A total of 1000 tissue 
spheroids were placed on one frame containing electrospun 
PU scaffold for morphometric, biomechanical, and bio-
chemical analysis. The number of tissue spheroids (1000) 
was calculated and selected based on the need to biofabri-
cate tissue-engineered construct of minimal sufficient size 
to be suitable for existing standard method of biomechani-
cal testing using standard equipment. At least five frames 
were used for every experiment. Tissue spheroids were also 
placed on non-adhesive hydrogel (agarose) as a control 
where formation of continuous (pore-free) tissue construct 
was observed.
Morphometric analysis of tissue-engineered 
construct
The holes in the tissue-engineered constructs were ana-
lyzed using two morphometric parameters: the number of 
holes per unit of area and the distribution of hole diameter. 
The number of holes was calculated on unit of standard 
area at standard magnification. The maximal diameter of 
hole was measured on large magnification. Five specimens 
were analyzed from both the control and the TGF-β1 treated 
groups after 1-week incubation. The light microscopy pho-
tographs were taken under standard magnification.
Biomechanical testing
The biomechanical properties of the tissue-engineered 
construct (force–elongation relationship) with and with-
out TGF-β1 treatment were estimated. Tissue specimens 
were glued between two fine waterproof sandpaper 
1500-b frames (Figure 1) using rubber cement (acid free). 
Two cuts were made along each side of each specimen. 
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The length and width of the each specimen in the frame 
was 10 and 5 mm, respectively. Tissue specimens were 
gripped at both ends with two-piece clamps that were 
lined with sandpaper such that the edges of the frame 
aligned with the end of the grips. Tensile tests were per-
formed at room temperature (20°C ± 1°C) using a Bose 
ElectroForce® 3200 Test System with load cell 50 N 
(Figure 2(b)). The frame improved traction of the tissue 
within the grips and prevented slippage during the test. 
The side faces of the frame were cut after the specimens 
were placed between the grips and the testing machine 
(Figure 1). Each specimen was loaded at a rate of 
0.2 mm/s until they ruptured (this elongation rate usually 
is used for quasi-static tensile testing of soft biological 
tissue and biomaterials), and the force-elongation curves 
were recorded.
Western blotting
Tissue-engineered constructs biofabricated from fused tis-
sue spheroids were collected and lysed in standard radio-
immunoprecipitation assay (RIPA: 50 mM Tris pH7.4, 
150 mM NaCl, 2 mM EDTA, 1% NP-40, 0.1%SDS, 0.5% 
sodium deoxycholate) buffer. Protein lysates were elec-
trophoresed and Western blotting was performed with 
a-collagen antibody (R&D Systems–Minneapolis, MN, 
USA), a-periostin (Abcam, Cambridge, MA, USA), or 
a-actin (Santa Cruz, Dallas, TX, USA). Detection was 
performed using the Femto-ECL detection kit (Pierce, 
Rockford, IL, USA).
Statistical analysis
Quantitative data were expressed as mean values plus one 
degree of standard deviation. A total of five specimens 
were analyzed from each group. The descriptive summary 
statistics are presented in terms of means and standard 
deviations. A p value of less than 0.05 was considered sta-
tistically significant. Analysis that compared only two 
groups was conducted using student t-tests with a p value 
of less than 0.05 to indicate statistical significance.
Results
Characterization of pre-stretched electrospun 
PU scaffold
Scanning electron microscopy demonstrated that the 
fibers were oriented perpendicularly to form a dense 
fibrous meshwork comprising fibers of variable diameter 
Figure 1. Scheme demonstrating the biomechanical testing procedure: (a) frame with scaffold and tissue spheroids (all dimensions 
in mm); (b) plastic frame supporting the electrospun polyurethane scaffold in Petri dish—the tissue spheroids do not fall through the 
scaffold; (c) tensile test of tissue construct sample; and (d) tissue construct sample preparation for tensile test (all dimensions in mm).
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(Figure 2(a) and (b)). The interfibrillar space is small enough 
to prevent the tissue spheroids from falling through the elec-
trospun scaffold (Figure 2(b)). The immediate formation of 
rounded holes after the rupture of the microfibrous mesh-
work is a clear indication that the electrospun scaffold was 
pre-stretched/under tension (Figure 2(c)). It is logical to 
assume that the tensions in the scaffold were the result of the 
drying of the electrospun PU fibers fixed to the rigid plastic 
support frames or induced by electrical forces during elec-
trospinning. Attempts to cut out the pre-stretched scaffold 
from the frame resulted in an immediate collapse of the deli-
cate pre-stretched microfibrillar meshwork.
Tissue spheroid adhesion and fusion on pre-
stretched electrospun PU scaffold
Tissue spheroids do not fall through the electrospun 
scaffold due to their relatively large size (300–400 µm) 
and therefore attached and spread on the scaffold sur-
face (Figure 3). Two, three, and seven closely placed 
tissue spheroids attached to the electrospun scaffold and 
underwent fusion to form a thick confluent tissue layer 
(Figure 3(a)–(c)). Therefore, small tissue-engineered 
constructs could be biofabricated from a small number 
of tissue spheroids to form a confluent tissue layer with-
out any holes. It has also been demonstrated that tissue 
spheroids can not only attach but also spread on electro-
spun matrices and change orientation of nanofibers 
by imposing traction forces (Figure 3(d)). Scanning 
electron microscopy demonstrates close interaction of 
tissue spheroids with electrospun matrices and incorpo-
ration of some electrospun fibers (Figure 3(e)). 
However, the fusion of 50 closely placed tissue sphe-
roids attached to an electrospun scaffold resulted in the 
formation of a non-confluent tissue layer with holes of 
different diameters and shape (Figure 4(a) and (b)). The 
addition of second and third layers of tissue spheroids 
did not eliminate or close these observed holes. 
Moreover, in this case, the preexisting holes evolved 
into larger crater-like structures (Figure 4(c)). Increasing 
the cultivation time to 2 weeks also failed to eliminate 
the holes. Tissue spheroids placed on pre-stretched elec-
trospun porous PU scaffolds fuse into tissue-engineered 
constructs with pores or one perforated tissue layer of 
fused tissue spheroids. The appearance of holes strongly 
correlates with an increased number of tissue spheroids 
forming the tissue construct.
Figure 2. Pre-stretched electrospun polyurethane scaffold: (a) scanning electron microscopy of the electrospun scaffold (small 
magnification); (b) scanning electron microscopy of the electrospun scaffold (large magnification); and (c) hole formation in the pre-
stretched electrospun polyurethane scaffold after rupture—white arrows indicate the centrifugal direction of stretch.
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Effect of TGF-β1 treatment on the pre-
stretched electrospun PU scaffold
Potent fibrogenic factor TGF-β1 capable of inducing 
extracellular matrix synthesis and deposition as well as 
contractile phenotype in employed human ADSCs was 
used to eliminate holes and mature the tissue constructs. 
In order to estimate the effect of TGF-β1 treatment on 
material properties of tissue-engineered constructs, bio-
mechanical testing was performed using cell-free electro-
spun scaffolds and tissue spheroid seeded electrospun 
scaffolds (but without TGF treatment) and as controls. 
The use of TGF-β1 dramatically reduced the number and 
diameter of the holes (Figure 5). The number of holes 
reduced from 3.4 ± 0.6 to 1.9 ± 0.3 (p < 0.05), and the 
diameter of holes reduced from 229 ± 63 to 110 ± 24 
(p < 0.05) (Figure 6). The observations revealed that after 
TGF-β1 treatment, the remaining tissue spheroids inside 
tissue-engineered constructs were more regularly packed. 
Moreover, the incubation with the TGF-β1 resulted in an 
increased maximal load and stiffness of tissue-engineered 
Figure 4. Hole formation during fusion of tissue spheroids attached to pre-stretched electrospun matrix. (a) 50 incompletely 
fused (with holes) tissue spheroids attached to the electrospun polyurethane scaffold (arrows indicate the areas of attachment-
dependent cell and tissue spreading). Scale bar—300 µm. (b) A hole between tissue spheroids that has not completely fused. Scale 
bar—300 µm. (c) Crater-like structures and persisted defects in the tissue construct after the addition of sequential layers of tissue 
spheroids. Scale bar—1 mm.
Figure 3. Tissue spheroids behavior on pre-stretched electrospun polyurethane scaffolds. (a) Single tissue spheroids attached 
to the electrospun polyurethane scaffold (arrows indicate the areas of attachment-dependent cell and tissue spreading). Scale 
bar—300 µm. (b) Three fused tissue spheroids attached to the electrospun polyurethane scaffold (arrows indicate the areas of 
attachment-dependent cell and tissue spreading). Scale bar—300 µm. (c) Seven fused tissue spheroids attached to the electrospun 
polyurethane scaffold (arrows indicate the areas of attachment-dependent cell and tissue spreading). Scale bar—300 µm. (d) Tissue 
spheroid on electrospun polyurethane scaffold. Tissue spheroid imposes traction forces on electrospun scaffold and changes original 
orientation of polyurethane fibers in centripetal direction. The original size and counters of tissue spheroid before spreading are 
outlined by dotted line. Scale bar—300 µm. (e) Adhesion of tissue spheroids to electrospun matrix—scanning electron microscopy.
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Figure 5. Formation of holes in tissue constructs as a result of incomplete tissue spheroids fusion on pre-stretched electrospun 
matrix and their dramatic reduction after TGF-β1 treatment. (a) Tissue spheroids placed on electrospun polyurethane scaffold 
before tissue fusion and without TGF-β1 treatment (control). Scale bar—1 mm. (b) Large holes in the fused tissue construct are 
formed on the pre-stretched electrospun polyurethane scaffold without TGF-β1 treatment (control). Scale bar—1 mm. (c) Tissue 
spheroids adherent to the electrospun polyurethane scaffold before tissue fusion and TGF-β1 treatment (experiment). Scale 
bar—1 mm. (d) A reduction in the size and density of holes in the fused tissue construct on pre-stretched electrospun polyurethane 
scaffold after TGF-β1 treatment (experiment). Scale bar—1 mm.
TGF: tissue growth factor.
Figure 6. Morphometric analysis of holes in tissue-engineered constructs: (a) number of holes per unit of tissue construct 
area reduced after treatment with TGF-β1 (A—after TGF-β1 treatment; B—control); (b) diameter of holes in tissue construct 
dramatically reduced after treatment with TGF-β1 (A—after TGF-β1 treatment; B—control).
TGF: tissue growth factor.
*The difference between values is statistically valid, p < 0.05.
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construct (Figure 7(a)). Finally, TGF-β1 was also shown 
to induce the synthesis of collagen type 1 and the matri-
cellular protein periostin in the tissue-engineered con-
struct (Figure 7(b)).
Elimination of holes in tissue-engineered 
construct after release from stretch
Two parallel cuts close to the border of the tissue construct 
were made in the scaffold in order to completely eliminate 
the tension present in the tissue-engineered construct. 
Many of the small holes instantly closed or collapsed and 
the large holes became elongated into an ellipsoid form 
after the tension was released. This confirmed the presence 
of tension in the scaffolds throughout the tissue fusion pro-
cess. From another point of view, even single attached and 
spread tissue spheroid imposed traction forces on the sup-
porting PU scaffold manifested by changing the original 
orientation of scaffold fibers (Figure 3(d)). Taken together, 
these data strongly indicate similarity to in vivo situations 
where soft tissues are usually pre-stretched/under tension 
as demonstrated by residual stresses. The observed tissue 
construct phenotypes are manifestation of balances 
between two competing forces: traction forces generated 
by attached, spread, and fused tissue spheroids from one 
side and forces imposed on tissue constructs by the tension 
in the pre-stretched nanofibers from another side (Figure 
2(c)). Although presented data strongly indicate the exist-
ence of competing physical forces operated on tissue– 
scaffold interface, the visualization, precision mapping, 
and direct or indirect measuring of these forces are sub-
jects of forthcoming investigations.
Formation of continuous (pore-free) tissue 
construct from tissue spheroids placed on non-
adhesive hydrogel
Tissue spheroids where placed on a non-adhesive hydrogel 
(agarose), and sequential stages of formation of continuous 
(hole-free) tissue constructs have been observed (Figure 8). 
Figure 7. The effects of TGF-β1 treatment on the biomechanical and biochemical properties of the tissue-engineered construct. 
(a) Force–displacement relationship for samples: 1—tissue construct after TGF-β1 treatment; 2—tissue construct without TGF-
β1 treatment; 3—polyurethane scaffold (control). TGF-β1 treatment increases rigidity of tissue constructs. (b) Protein expression 
of the alpha chains (a1 and a2) as well as pro-collagen precursors (pro-a1, pro-a2) significantly increased after TGF-β1 treatment. 
The expression of periostin, a known regulator of collagen cross-linking and synthesis, also significantly increased after TGF-β1 
treatment. Molecular weight markers (MW) are labeled and Actin was used as a normalization control for protein loading.
TGF: tissue growth factor.
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Formation of continuous tissue constructs from fusogenic 
tissue spheroids non-attached to substrates due to its non-
adhesivity was associated with a dramatic reduction of con-
struct size. The experiments with formation of continuous 
tissue constructs on non-adhesive hydrogel in the absence 
of attachment of tissue spheroids to a substrate confirm the 
fact that attachment of tissue spheroids to pre-stretched 
elastic PU substrate interferes with continuous tissue con-
struct formation due to tethering (attachment and immobi-
lization) effects.
Discussion
The main observation in this study is that tissue spheroids 
can attach, spread, and form relatively thick tissue layer on 
thin pre-stretched electrospun PU scaffolds when placed 
closely together. This study indicates that electrospun scaf-
folds provide an adhesion permissive surface for tissue 
spheroids. The observation of incomplete tissue spheroid 
fusion and the appearance of holes on pre-stretched elec-
trospun PU scaffolds is an interesting and unexpected phe-
nomenon. A logical explanation of the phenomenon is the 
well-known fact that the fusion of tissue spheroids in 
closely placed hanging drops results in “new” tissue sphe-
roids that are smaller in diameter than the sum of the diam-
eter of the two “maternal” spheroids. It is also greatly 
accepted that surface tension is the main force behind tis-
sue spheroid fusion.18 However, this situation dramatically 
changes when tissue spheroids are subject to additional 
“tethering” effects or adhesive forces from the substrate. 
One could assume that constructs engineered to accom-
modate the tissue compaction associated with tissue fusion 
processes34 would be flexible enough to form a confluent 
tissue construct. For example, it was shown that hundreds 
of tissue spheroids could fuse on adhesive collagen sub-
strates without the formation of any holes.37 However, it is 
also possible to theoretically argue that as the number of 
tissue spheroids increases from hundreds to thousands, it 
will be possible to observe formation of hole defects 
because collagen hydrogel is attached or fixed to the Petri 
dish wall or plastic multiwall and, thus, pre-stretched. 
Finally, it is possible to assume that variability in tissue 
spheroid size and shape could be responsible for the for-
mation of holes. However, the dense packing of spheres of 
uniform size in confined space results in the formation of 
packing defects. It is logical to assume that tissue fusion 
process unrestricted by “tethering effect” must serve as a 
biological mechanism to eliminate or prevent any packing 
defects. Our experiment with tissue spheroid fusion on 
non-adhesive substrates (such as agarose hydrogel) dem-
onstrates that the use of even thousands of tissue spheroids 
does not result in any holes or defects. Thus, “tethering 
effect” induced hole defects likely occurred when tissue 
spheroids attach to the electrospun nanofiber substrate.
Another significant observation is the demonstration of 
the “restoration” (hole closing) effects of TGF-β to pro-
mote confluency of tissue constructs biofabricated from tis-
sue spheroids on the pre-stretched electrospun PU scaffold. 
There are at least two theoretical explanations on this effect. 
The first is that TGF-β could be acting as a potent fibro-
genic factor that induces the synthesis of collagen type 1, 
and other extracellular matrices that result in the increased 
cohesion of tissue spheroids. Our findings that report an 
increased synthesis of collagen and periostin support this 
hypothesis. It has recently been shown that periostin 
induces collagen fibrillogenesis38 and acts as a maturogenic 
factor.39 It was also recently shown that periostin can con-
tract cell-free collagen hydrogel40 and that the addition of 
certain soluble extracellular matrix proteins, such as 
fibronectin, increases the cohesion (compaction) of tissue 
spheroids.41,42 An alternate explanation is that TGF-β could 
differentiate some stem cells into contractile myofibro-
blasts and/or smooth muscle cells that then contract tissue 
constructs. It is widely recognized that TGF-β increases the 
contraction of fibroblast populated collagen hydrogel43 and 
induces the expression of alpha smooth muscle actin—a 
marker of myofibroblast.44 However, it is not possible to 
rule out the synergistic effects of both compaction and 
Figure 8. Tissue spheroid fusion on non-adhesive hydrogel (agarose). (a) Tissue spheroids placed on non-adhesive hydrogel 
(agarose) before tissue fusion. Scale bar—1 mm. (b) Intermediate step of tissue spheroid fusion placed on non-adhesive (agarose) 
hydrogel. Small holes still persist (24 h after beginning of fusion). Scale bar—1 mm. (c) Complete fusion of tissue spheroids placed 
on non-adhesive hydrogel (agarose) and formation of tissue construct without any holes or defects (72 h after beginning of fusion). 
Scale bar—1 mm.
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contraction mechanisms. If other “maturogenic” factors 
impose similar effects on incompletely fused tissue layer of 
tissue spheroids, then a miniaturized version of this assay 
could serve as a quantitative in vitro assay for the study of 
tissue maturation and even offer a new method to high 
throughput screen maturation factors by the automated 
image analysis (detection and estimation of the number, 
density, and size distribution of holes).
Finally, the reported observation that holes instantly 
disappear when tissue-engineered constructs are cut from 
the pre-stretched supporting PU scaffold supports the 
hypothesis that electrospun scaffold nanofiber tension 
forces are maintained throughout the tissue fusion process 
and that the interaction between surface tension forces 
associated with tissue fusion and the adhesive forces 
between the spheroids and the underlying nanofiber tem-
plate prevent complete tissue fusion. Moreover, at least 
practically, it would be impossible to completely eliminate 
these competing forces in resulted tissue-engineered con-
structs as long as pre-stretched (or not pre-stretched) elec-
trospun elastic nanofibers and tissue spheroids physically 
interact and simultaneously impose physical traction 
forces on each other. Thus, finding a proper balance of 
these competing physical forces is probably a more realis-
tic option and more practical approach. In this context, an 
assortment of carefully tailored and calibrated pre-
stretched electrospun scaffolds could potentially comprise 
a technological platform for the study and measure of 
forces directing tissue spheroid fusion in more complex 
biomechanical environments. For example, such research 
tools could be useful for the precise measurement of the 
surface tension forces generated by fusing tissue spheroids 
and the scaffold imposed tethering forces interfering with 
tissue spheroid fusion process.
The flexible elastic and pre-stretched substrates with 
adhered tissue spheroids undergoing tissue fusion could 
also be potentially used for the design of self-directed self-
assembling or self-folding tissue constructs in emerging 
four-dimensional (4D) printing and potentially 4D bio-
printing technology.45 Another potential application of 
pre-stretched PU nanofiber scaffolds could be the use for 
accelerating tissue maturation by imposing precisely cali-
brated mechanical stretch on tissue engineering constructs 
in bioreactor-based mechanical conditioning. Finally, a 
hybrid compliant scaffold could be designed and fabri-
cated with pre-stretched electrospun PU for the biomi-
metic tissue engineering of vascular constructs formed 
from fusogenic vascular tissue spheroids placed on elec-
trospun matrices.
Conclusion
A thin electrospun PU nanofiber scaffold was used as a 
template for spheroid fusion. Tissue spheroids attached and 
spread on thin electrospun PU scaffolds and, to a certain 
degree, will undergo tissue fusion with the formation of a 
thick confluent tissue layer attached to the scaffold. With 
increasing number of tissue spheroids, the tissue fusion on 
pre-stretched electrospun scaffold is incomplete and results 
in the formation of a tissue layer with hole defects. 
However, the size and frequency of these holes were dra-
matically reduced with the addition of maturogenic factors 
such as TGF-β. Our findings highlight the complexity of 
the spheroid fusion process on adhesive substrates and 
demonstrate the potential of nanofiber scaffolds as a tool to 
measure forces associated with this process. Furthermore, 
the formation of confluent tissue layers on thin elastic 
nanofiber scaffolds with factor treatment demonstrates 
their potential as a template for spheroid fusion and subse-
quent biofabrication of higher order tissue structures.
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